Home » Stocks » Materialise

Materialise NV (MTLS)

Stock Price: $22.41 USD -1.43 (-6.00%)
Updated Jul 31, 2020 4:00 PM EDT - Market closed
After-hours: $22.40 -0.01 (-0.05%) Jul 31, 5:52 PM

Stock Price Chart

Key Info

Market Cap 1.19B
Revenue (ttm) 220.99M
Net Income (ttm) 1.85M
Shares Out 53.17M
EPS (ttm) 0.10
PE Ratio 224.10
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 31, 2020
Last Price $22.41
Previous Close $23.84
Change ($) -1.43
Change (%) -6.00%
Day's Open 23.94
Day's Range 22.26 - 24.29
Day's Volume 208,266
52-Week Range 10.65 - 28.99

More Stats

Market Cap 1.19B
Enterprise Value 1.19B
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 53.17M
Float 19.60M
EPS (basic) n/a
EPS (diluted) 0.10
FCF / Share 0.32
Dividend n/a
Dividend Yield n/a
Earnings Yield 0.45%
FCF Yield 1.43%
Payout Ratio n/a
Shares Short 1.09M
Short Ratio 8.59
Short % of Float n/a
Beta 0.38
PE Ratio 224.10
Forward PE n/a
P/FCF Ratio 69.73
PS Ratio 5.39
PB Ratio 8.12
Revenue 220.99M
Operating Income 7.88M
Net Income 1.85M
Free Cash Flow 17.09M
Net Cash 1.08M
Net Cash / Share 0.02
Gross Margin 55.78%
Operating Margin 3.57%
Profit Margin 0.80%
FCF Margin 7.73%
ROA 0.54%
ROE -1.83%
ROIC 3.90%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 0
Overweight 0
Hold 2
Underweight 1
Sell 0

Analyst Consensus: Hold

Price Target

$18.44*
(-17.73% downside)
Low
17.1
Current: $22.41
High
19.8
Target: 18.44
*Average 12-month USD price target from 2 stock analysts.

Financial Performance

Financial numbers in millions EUR.

Financial Overview

Year20192018201720162015201420132012
Revenue19718514311410281.3668.7259.11
Revenue Growth6.47%29.56%24.54%12.19%25.42%18.38%16.27%-
Gross Profit11010279.6267.7759.0748.9641.5335.32
Operating Income7.025.160.390.11-3.890.334.422.11
Net Income1.653.03-2.12-3.02-2.862.063.511.55
Shares Outstanding52.8947.3347.3347.3347.1547.0747.07-
Earnings Per Share0.030.06-0.04-0.06-0.060.050.090.04
EPS Growth-50%-----44.44%125%-
Operating Cash Flow28.4028.329.958.502.354.848.886.11
Capital Expenditures-13.19-17.99-27.51-10.31-8.57-9.48-2.42-4.17
Free Cash Flow15.2110.33-17.56-1.81-6.22-4.646.471.95
Cash & Equivalents12911643.1855.9150.7361.0212.606.42
Total Debt12810694.5633.8121.0917.3516.3215.67
Net Cash / Debt0.969.47-51.3822.1129.6443.67-3.72-9.26
Assets34931323516214413355.6946.68
Liabilities20717715882.8961.1848.0537.9533.34
Book Value14013677.0579.0382.9685.3017.7313.30
Numbers in millions EUR, except per-share numbers.

Company Profile

Company Details

Full Name Materialise NV
Country Belgium
Employees 2,177
CEO Wilfried Vancraen

Stock Information

Ticker Symbol MTLS
Stock Exchange NASDAQ
Sector Technology
Industry Software—Application
Unique Identifier NASDAQ: MTLS
IPO Date June 25, 2014

Description

Materialise NV provides additive manufacturing and medical software, and 3D printing services in Europe, the Americas, Europe and Africa, and the Asia-Pacific. The company's Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design packages and 3D scanners. This segment serves 3D printing machine original equipment manufacturers; manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. Its Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The company's Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. It has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Global Orthopaedic Technology Pty Ltd; Limacorporate Spa; Mathys AG; Howmedica Osteonics Corp.; Corin Ltd.; and Fluidda, as well as a partnership with Sigma Labs, Inc. The company was founded in 1990 and is headquartered in Leuven, Belgium.